Atrium Evolution Series – Diversified Fund AEF 9 Class P Units
As at 31 July 2025
Features
Information
Ratings & awards
A rating is only one factor to be taken into account when deciding whether to invest.
Investment objective
To maximise returns while ensuring portfolio risk, or volatility, does not exceed 9% over a rolling three (3) year time period.
Investment strategy
The Fund has a Risk Targeted, multi asset investment strategy.
Atrium uses a dynamic, unconstrained approach to asset allocation providing flexibility to take full advantage of opportunities in the market and to mitigate downside risk.
The Fund may be invested in a broad universe of assets across multiple asset classes.
Atrium may also use derivatives to gain exposure to assets or asset classes more efficiently, for currency management, and to mitigate downside risk.
Building portfolios that smooth out volatility
Atrium’s Risk Targeted investment approach aims to offer investors a smoother investment journey. By challenging conventional thinking and allocating to a wide array of investments, we construct truly diversified portfolios that seek to maximise opportunity and manage risk.
During market downturns we focus on minimizing losses to help investors achieve consistent growth over the long-term with less volatility. This is important to us because we care about the entire investment journey, not just the destination.
Our disciplined process is underpinned by three core principles that have enabled us to effectively pursue our investment objectives over a long time horizon.
Focus on risk first
Seek consistency of returns
Seek to preserve capital
Source: Atrium, for illustrative purposes only. This graph is not a guarantee of future performance and undue reliance should not be placed upon it.
Important Information:
The information in this document (Information) has been prepared and issued by Atrium Investment Management Pty Ltd (ABN 17 137 088 745, AFSL 338 634) (Atrium). The Trust Company (RE Services) Limited (ABN 45 003 278 831, AFSL 235 150) is the Responsible Entity of the Atrium Evolution Series – Diversified Fund (ARSN 151 191 776) (Fund). The Information is of a general nature only and does not take into account the objectives, financial situation or needs of any person. Before acting on the Information, investors should consider its appropriateness having regard to their own objectives, financial situation and needs and obtain professional advice. No liability is accepted for any loss or damage as a result of any reliance on the Information. The ‘return objective’ is an internal return objective which is a measure that Atrium considers internally when managing the portfolio. Internal return objectives are not performance benchmarks and are not features set out in the Fund’s Product Disclosure Statement (PDS). Investors should consider the Fund’s PDS and Target Market Determination (TMD) (available from www.atriuminvest.com.au) before making any investment decision. Past performance is not a reliable indicator of future performance. Future performance and return of capital are not guaranteed.
The ratings published 04/2025 Atrium Evolution Series – Diversified Fund AEF 5, 04/2025 Atrium Evolution Series – Diversified Fund AEF 7, 04/2025 Atrium Evolution Series – Diversified Fund AEF 7P Units, 04/2025 Atrium Evolution Series – Diversified Fund AEF 9, 04/2025 Atrium Evolution Series – Diversified Fund AEF 9P Units are issued by Lonsec Research Pty Ltd ABN 11 151 658 561 AFSL 421 445 (Lonsec Research). Ratings are general advice only, and have been prepared without taking account of your objectives, financial situation or needs. Consider your personal circumstances, read the product disclosure statement and seek independent financial advice before investing. The rating is not a recommendation to purchase, sell or hold any product. Past performance information is not indicative of future performance. Ratings are subject to change without notice and Lonsec assumes no obligation to update. Lonsec Research uses objective criteria and receives a fee from the Fund Manager. Visit www.lonsec.com.au for ratings information and to access the full report. © 2025 Lonsec. All rights reserved.
Powered by data from FE fundinfo
Source: Atrium Investment Management, Bloomberg. Performance shown as at the date of this report. Inception date is 11/11/2022. Past performance is not a reliable indicator of future performance. Future performance and return of capital is not guaranteed. Performance is after fees and costs and assumes re-investment of all distributions. Return objectives are internal return objectives which are measures that Atrium considers internally when managing the portfolio. Internal return objectives are not performance benchmarks and are not features set out in the PDS. Note that the internal return objectives for AEF 7P Units and AEF 9P Units align to the performance return hurdles for these Units (as set out in the PDS for these performance-based fee products). Please refer to the Fund’s Product Disclosure Statement (PDS) for more information on returns.
Performance
| Since inception (% p.a.) | 10 Years (% p.a.) | 7 years (% p.a.) | 5 years (% p.a.) | 3 years (% p.a.) | 1 year | 6 months | 3 months | 1 month | |
|---|---|---|---|---|---|---|---|---|---|
| Portfolio | 9.04% | 9.87% | 3.38% | 5.63% | 1.03% | ||||
| Objective | 8.55% | 8.68% | 4.14% | 2.05% | 0.68% |
Objective refers to the Return objective as stated in the Key Facts table.
Important Information:
The information in this document (Information) has been prepared and issued by Atrium Investment Management Pty Ltd (ABN 17 137 088 745, AFSL 338 634) (Atrium). The Trust Company (RE Services) Limited (ABN 45 003 278 831, AFSL 235 150) is the Responsible Entity of the Atrium Evolution Series – Diversified Fund (ARSN 151 191 776) (Fund). The Information is of a general nature only and does not take into account the objectives, financial situation or needs of any person. Before acting on the Information, investors should consider its appropriateness having regard to their own objectives, financial situation and needs and obtain professional advice. No liability is accepted for any loss or damage as a result of any reliance on the Information. The ‘return objective’ is an internal return objective which is a measure that Atrium considers internally when managing the portfolio. Internal return objectives are not performance benchmarks and are not features set out in the Fund’s Product Disclosure Statement (PDS). Investors should consider the Fund’s PDS and Target Market Determination (TMD) (available from www.atriuminvest.com.au) before making any investment decision. Past performance is not a reliable indicator of future performance. Future performance and return of capital are not guaranteed.
Powered by data from FE fundinfo
Asset allocation
| Rates & credit | 3.33% | |
| Cash | 0.90% | |
| Australian equities | 20.66% | |
| International equities | 45.65% | |
| Listed infrastructure | 4.02% | |
| Liquid alternatives | 14.66% | |
| Private markets | 10.78% |
Atrium aims to achieve its investment objectives by investing across a range of asset classes on a global basis that provide exposure to different risk factors.
Each asset is included in the Portfolio for its ability to contribute to returns on a stand alone basis.
The investment universe comprises of 3 broad categories - Preservers, Growth Drivers and Diversifiers.
 | PreserversAssets that protect the portfolio during periods of heightened equity market volatility and preserve capital, such as cash, government bonds and high quality investment grade bonds. |
 | Growth DriversAssets that are expected to deliver higher rates of return over time with higher levels of associated volatility (risk). This predominantly comprises equities but also includes other assets that are highly correlated to equities such as listed property and infrastructure. |
 | DiversifiersAssets that generate additional real returns, with performance that is typically uncorrelated to the growth drivers and preservers within the portfolio.Importantly, they are a source of portfolio diversification away from equity market and interest rate risks, such as liquid alternatives and private markets. |
Important Information:
The information in this document (Information) has been prepared and issued by Atrium Investment Management Pty Ltd (ABN 17 137 088 745, AFSL 338 634) (Atrium). The Trust Company (RE Services) Limited (ABN 45 003 278 831, AFSL 235 150) is the Responsible Entity of the Atrium Evolution Series – Diversified Fund (ARSN 151 191 776) (Fund). The Information is of a general nature only and does not take into account the objectives, financial situation or needs of any person. Before acting on the Information, investors should consider its appropriateness having regard to their own objectives, financial situation and needs and obtain professional advice. No liability is accepted for any loss or damage as a result of any reliance on the Information. The ‘return objective’ is an internal return objective which is a measure that Atrium considers internally when managing the portfolio. Internal return objectives are not performance benchmarks and are not features set out in the Fund’s Product Disclosure Statement (PDS). Investors should consider the Fund’s PDS and Target Market Determination (TMD) (available from www.atriuminvest.com.au) before making any investment decision. Past performance is not a reliable indicator of future performance. Future performance and return of capital are not guaranteed.
Powered by data from FE fundinfo
Top holdings
| Holding | Weight | Asset Class |
|---|---|---|
| RUSSELL AUSTRALIAN EQUITY OPPORTUNITIES FUND | 15.39% | Australian equities |
| ANTIPODES GLOBAL FUND LONG UCITS CLASS S | 9.26% | International equities |
| HYPERION GLOBAL GROWTH COMPANIES FUND CLASS C | 7.11% | International equities |
| FAIRLIGHT GLOBAL SMALL AND MID CAP (SMID) FUND - FOUNDATION CLASS | 7.00% | International equities |
| ISHARES MSCI USA EQUAL WEIGHTED ETF | 6.88% | International equities |
| SFE S&P ASX 200 INDEX FUTURE EXP 19/09/2025 | 5.27% | Australian equities |
| CME MINI S&P FUT INDEX FUTURE EXP SEPT 25 | 4.73% | International equities |
| RUSSELL GLOBAL LISTED REAL ASSET FUND | 4.02% | Listed infrastructure |
| CROWN ATRIUM SEGREGATED PORTFOLIO SERIES 1 USD | 3.92% | Liquid alternatives |
| VANGUARD FTSE EMERGING MARKETS ETF (US LISTED) | 3.29% | Emerging markets |
Important Information:
The information in this document (Information) has been prepared and issued by Atrium Investment Management Pty Ltd (ABN 17 137 088 745, AFSL 338 634) (Atrium). The Trust Company (RE Services) Limited (ABN 45 003 278 831, AFSL 235 150) is the Responsible Entity of the Atrium Evolution Series – Diversified Fund (ARSN 151 191 776) (Fund). The Information is of a general nature only and does not take into account the objectives, financial situation or needs of any person. Before acting on the Information, investors should consider its appropriateness having regard to their own objectives, financial situation and needs and obtain professional advice. No liability is accepted for any loss or damage as a result of any reliance on the Information. Investors should consider the Fund’s Product Disclosure Statement (PDS) and Target Market Determination (TMD) (available from www.atriuminvest.com.au) before making any investment decision. Past performance is not a reliable indicator of future performance. Future performance and return of capital are not guaranteed.
Powered by data from FE fundinfo
Market update
Global markets performed well in July 2025, driven by positive trade developments. The US finalised trade deals with the EU, Japan, South Korea, and Southeast Asian nations, reducing tariffs and averting major trade wars. US-China talks extended a tariff truce, while Canada and Mexico continued negotiations. Central banks globally maintained cautious stances, with the US Federal Reserve holding rates steady amid mixed economic data, including weaker-than-expected jobs growth. The European Central Bank and Bank of Japan also left rates unchanged, while the Bank of England lowered rates in early August. Corporate earnings were mostly positive, with tech giants like NVIDIA, Alphabet, and Microsoft leading gains, though some companies like BlackRock and eBay missed expectations. Chinese GDP growth slowed slightly but exceeded market forecasts.
In Australia, the Reserve Bank of Australia (RBA) surprised markets by holding rates at 3.85%, citing easing inflation and labour market uncertainties. Inflation data showed further moderation, with core inflation within the RBA’s target range. The unemployment rate rose to 4.3%, its highest in over three years. The Australian dollar made modest gains, supported by easing global trade tensions and stronger iron ore prices.
Macroeconomic trends highlighted mixed signals. US inflation rose, driven partly by tariffs, while labour market data revealed weaker-than-expected job growth. Euro-zone growth slowed, and Japan revised its growth forecast upward following a trade deal with the US. Global trade uncertainty remains a key risk, though sentiment has improved with easing tariff tensions.
Looking ahead, we continue to see opportunity in equity markets as we view upcoming cuts in cash rates as supportive. Valuations are attractive in non-US equities, government bonds, private credit, and infrastructure. US equities remain at elevated valuations, while emerging markets, particularly China, could benefit from fiscal initiatives. The USD appears overvalued, with medium-term value seen in the AUD. Diversification remains critical amid ongoing uncertainties.
Performance
The Fund experienced another positive month with equities continuing to be the primary driver of returns for the strategy. Improved clarity on global trade outcomes provided support for global equities. Global developed markets outperformed the local market, led by strong US equity returns.
Although equities were the strongest contributors to performance, liquid alternatives also performed reasonably well, making a decent overall contribution to returns. Private markets and rates and credit further provided small positive contributions.
In equities, mega cap technology stocks led markets higher, an area in which active managers tend to be underweight. This is reflected in the underperformance of Antipodes, Hyperion, and Fairlight. Our emerging market allocation with Northcape was also positive but lagged its benchmark. Within Australian equities, Ausbil continued their outperformance, however, Russell slightly underperformed and Firetrail also underperformed their benchmark.
In liquid alternatives, the P/E Global FX Alpha Fund had a strong month driven by a long USD, short EUR position. Crown Atrium Segregated Portfolio and Crown Diversified Macro also had solid gains while Man Alternative Risk Premia declined.
Rates and credit strategies were positive, with high yield managers delivering strong contributions.
Portfolio changes
There were no significant changes to holdings over the month. The Fund remains fully invested with equity positioning above the Fund’s long-run average although we have increased put option protection to manage downside risk.
Outlook
As previously noted, we remain broadly supportive of a larger equity allocation in the medium term. We are keeping a close eye on the US labour market as a leading indicator of risk to growth. Following a strong US earnings season and supportive monetary and fiscal policy changes, we remain optimistic about better results for small and emerging market companies.
Important Information:
The information in this document (Information) has been prepared and issued by Atrium Investment Management Pty Ltd (ABN 17 137 088 745, AFSL 338 634) (Atrium). The Trust Company (RE Services) Limited (ABN 45 003 278 831, AFSL 235 150) is the Responsible Entity of the Atrium Evolution Series – Diversified Fund (ARSN 151 191 776) (Fund). The Information is of a general nature only and does not take into account the objectives, financial situation or needs of any person. Before acting on the Information, investors should consider its appropriateness having regard to their own objectives, financial situation and needs and obtain professional advice. No liability is accepted for any loss or damage as a result of any reliance on the Information. The ‘return objective’ is an internal return objective which is a measure that Atrium considers internally when managing the portfolio. Internal return objectives are not performance benchmarks and are not features set out in the Fund’s Product Disclosure Statement (PDS). Investors should consider the Fund’s PDS and Target Market Determination (TMD) (available from www.atriuminvest.com.au) before making any investment decision. Past performance is not a reliable indicator of future performance. Future performance and return of capital are not guaranteed.
Powered by data from FE fundinfo
Important Information:
The information in this document (Information) has been prepared and issued by Atrium Investment Management Pty Ltd (ABN 17 137 088 745, AFSL 338 634) (Atrium). The Trust Company (RE Services) Limited (ABN 45 003 278 831, AFSL 235 150) is the Responsible Entity of the Atrium Evolution Series – Diversified Fund (ARSN 151 191 776) (Fund). The Information is of a general nature only and does not take into account the objectives, financial situation or needs of any person. Before acting on the Information, investors should consider its appropriateness having regard to their own objectives, financial situation and needs and obtain professional advice. No liability is accepted for any loss or damage as a result of any reliance on the Information. The ‘return objective’ is an internal return objective which is a measure that Atrium considers internally when managing the portfolio. Internal return objectives are not performance benchmarks and are not features set out in the Fund’s Product Disclosure Statement (PDS). Investors should consider the Fund’s PDS and Target Market Determination (TMD) (available from www.atriuminvest.com.au) before making any investment decision. Past performance is not a reliable indicator of future performance. Future performance and return of capital are not guaranteed.
Powered by data from FE fundinfo